MiR-1224-5p reverses gefitinib resistance in non-small-cell lung cancer cells by modulating RFX5/YAP1/HIF1a axis.

MLA

Hanxu Tang, et al. “MiR-1224-5p Reverses Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells by Modulating RFX5/YAP1/HIF1a Axis.” Tropical Journal of Pharmaceutical Research, vol. 23, no. 2, Feb. 2024, pp. 263–72. EBSCOhost, https://doi.org/10.4314/tjpr.v23i2.5.

APA

Hanxu Tang, Chunhua Liu, Xiangchun Yu, Weiwei Zhao, Zexin Gu, Ying Liu, Xin Zheng, & Xiangru Meng. (2024). MiR-1224-5p reverses gefitinib resistance in non-small-cell lung cancer cells by modulating RFX5/YAP1/HIF1a axis. Tropical Journal of Pharmaceutical Research, 23(2), 263–272. https://doi.org/10.4314/tjpr.v23i2.5

Chicago

Hanxu Tang, Chunhua Liu, Xiangchun Yu, Weiwei Zhao, Zexin Gu, Ying Liu, Xin Zheng, and Xiangru Meng. 2024. “MiR-1224-5p Reverses Gefitinib Resistance in Non-Small-Cell Lung Cancer Cells by Modulating RFX5/YAP1/HIF1a Axis.” Tropical Journal of Pharmaceutical Research 23 (2): 263–72. doi:10.4314/tjpr.v23i2.5.